Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pharma index rebounded from early losses to rise nearly 1%, crossing the 25,000 mark and hitting a fresh 52-week high of 25…
Market veteran Ambareesh Baliga suggests pharmaceutical stocks offer a safe haven amidst currency volatility and cautious foreign investor sentiment. He advises focusing on top-tier pharma companies. Baliga also expresses caution on jewellery stocks due to in…
Market expert Dipan Mehta finds India's current earnings season strong. He notes that future quarters will test corporate India due to potential Iran-US war impacts. Mehta favors pharma stocks for their growth potential and attractive valuations. Specialty ch…